Liu H, Nakagawa T, Kanematsu T, Uchida T, Tsuji S (May 1999). "Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene". Journal of Neurochemistry. 72 (5): 1781–1790. doi:10.1046/j.1471-4159.1999.0721781.x. PMID10217254. S2CID8214053.
Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, etal. (January 2002). "Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21". Nature Genetics. 30 (1): 21–22. doi:10.1038/ng796. PMID11743579. S2CID11340817.
Cuesta A, Pedrola L, Sevilla T, García-Planells J, Chumillas MJ, Mayordomo F, etal. (January 2002). "The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease". Nature Genetics. 30 (1): 22–25. doi:10.1038/ng798. PMID11743580. S2CID1120901.
Nelis E, Erdem S, Van Den Bergh PY, Belpaire-Dethiou MC, Ceuterick C, Van Gerwen V, etal. (December 2002). "Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy". Neurology. 59 (12): 1865–1872. doi:10.1212/01.wnl.0000036272.36047.54. PMID12499475. S2CID34484332.
Azzedine H, Ruberg M, Ente D, Gilardeau C, Périé S, Wechsler B, etal. (May 2003). "Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene". Neuromuscular Disorders. 13 (4): 341–346. doi:10.1016/S0960-8966(02)00281-X. PMID12868504. S2CID28668205.
Ammar N, Nelis E, Merlini L, Barisić N, Amouri R, Ceuterick C, etal. (November 2003). "Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease". Neuromuscular Disorders. 13 (9): 720–728. doi:10.1016/S0960-8966(03)00093-2. PMID14561495. S2CID22727918.
Stojkovic T, Latour P, Viet G, de Seze J, Hurtevent JF, Vandenberghe A, etal. (April 2004). "Vocal cord and diaphragm paralysis, as clinical features of a French family with autosomal recessive Charcot-Marie-Tooth disease, associated with a new mutation in the GDAP1 gene". Neuromuscular Disorders. 14 (4): 261–264. doi:10.1016/j.nmd.2004.01.003. PMID15019704. S2CID28092053.
Kabzińska D, Kochański A, Drac H, Rowińska-Marcińska K, Ryniewicz B, Pedrola L, etal. (February 2006). "A novel Met116Thr mutation in the GDAP1 gene in a Polish family with the axonal recessive Charcot-Marie-Tooth type 4 disease". Journal of the Neurological Sciences. 241 (1–2): 7–11. doi:10.1016/j.jns.2005.10.002. PMID16343542. S2CID11433631.
Biancheri R, Zara F, Striano P, Pedemonte M, Cassandrini D, Stringara S, etal. (September 2006). "GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features". Journal of Neurology. 253 (9): 1234–1235. doi:10.1007/s00415-006-0149-4. hdl:11567/314987. PMID16607474. S2CID1418015.
Shield AJ, Murray TP, Board PG (2006). "Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase". Biochemical and Biophysical Research Communications. 347 (4): 859–866. doi:10.1016/j.bbrc.2006.06.189. PMID16857173.
Baránková L, Vyhnálková E, Züchner S, Mazanec R, Sakmaryová I, Vondrácek P, etal. (June 2007). "GDAP1 mutations in Czech families with early-onset CMT". Neuromuscular Disorders. 17 (6): 482–489. doi:10.1016/j.nmd.2007.02.010. PMID17433678. S2CID29318571.
Bird TD (2013-09-26). "Charcot-Marie-Tooth Neuropathy Type 4 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY". Charcot-Marie-Tooth Neuropathy Type 4. University of Washington, Seattle. PMID20301641. NBK1468. In GeneReviews harvnb error: no target: CITEREFGeneReviews (help)